Comment on Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients. [J Antimicrob Chemother. 2016]
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings
Cucchetto, Giulia;Lanzafame, Massimiliano;Nicolè, Stefano;Lattuada, Emanuela;Concia, Ercole
2017-01-01
Abstract
Comment on Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients. [J Antimicrob Chemother. 2016]
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
